Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

NCT07269197 · clinicaltrials.gov ↗

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease
Diabetes Mellitus, Type 2

Interventions

DRUG: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor

Sponsor

Josip Juraj Strossmayer University of Osijek